Literature DB >> 1718950

Synthesis of protein C in human umbilical vein endothelial cells.

S Tanabe1, T Sugo, M Matsuda.   

Abstract

By monitoring the activation of protein C and the regulation of factor Xa-catalyzed thrombin formation by the activated protein C (APC) on the surface of human umbilical vein endothelial cells (HUVEC), we found that functional protein C was synthesized in cultured HUVEC and expressed thereon in the presence of vitamin K. Furthermore, without exogenously added protein S, time-dependent and saturable accumulation of APC (20 fmol APC/10(5) cells) on the surface of HUVEC was observed. During prothrombin activation by the complex of membrane-bound factor Xa and endogenous factor Va formed on the surface of HUVEC, APC was generated, and the rate of thrombin formation decreased. Treatment of HUVEC with an antibody that inhibits the APC-catalyzed inactivation of endogenous factor Va clearly quenched the activity of surface-associated APC. Immunostaining of HUVEC with a horseradish peroxidase (HRP)-conjugated antibody that solely recognizes human protein C confirmed the presence of protein C on the surface of HUVEC. Northern blot analysis revealed that an about 1.8 kb mRNA species derived from HUVEC was hybridized with 32P-labeled protein C cDNA, as in the case of those from HepG2, which are known to synthesize normal protein C. The increase in the amount of protein C mRNA in HUVEC in parallel with cell growth provided supporting evidence for the synthesis of protein C during the culture of HUVEC. These results indicate that blood coagulation is regulated by endogenously generated and activated protein C, together with or without protein S, through inactivation of factor Va on the surface of endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1718950     DOI: 10.1093/oxfordjournals.jbchem.a123481

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  8 in total

1.  Modeling zymogen protein C.

Authors:  L Perera; C Foley; T A Darden; D Stafford; T Mather; C T Esmon; L G Pedersen
Journal:  Biophys J       Date:  2000-12       Impact factor: 4.033

2.  Deficiency of natural anticoagulant proteins C, S, and antithrombin in portal vein thrombosis: a secondary phenomenon?

Authors:  N C Fisher; J T Wilde; J Roper; E Elias
Journal:  Gut       Date:  2000-04       Impact factor: 23.059

3.  Endogenous protein C is essential for the functional integrity of human endothelial cells.

Authors:  Meilang Xue; Nikita Minhas; Shu-Oi Chow; Suat Dervish; Philip N Sambrook; Lyn March; Christopher J Jackson
Journal:  Cell Mol Life Sci       Date:  2010-02-03       Impact factor: 9.261

4.  Extrahepatic expression and regulation of protein C in the mouse.

Authors:  K Yamamoto; D J Loskutoff
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

5.  Inactivation of the gene for anticoagulant protein C causes lethal perinatal consumptive coagulopathy in mice.

Authors:  L R Jalbert; E D Rosen; L Moons; J C Chan; P Carmeliet; D Collen; F J Castellino
Journal:  J Clin Invest       Date:  1998-10-15       Impact factor: 14.808

6.  Symptomatic hereditary type-II protein C deficiency caused by a missense mutation in exon IX of the protein C gene (Gly381 to Ser).

Authors:  E Wittmann; J Walter; I Pabinger-Fasching; H H Watzke
Journal:  Ann Hematol       Date:  1994-05       Impact factor: 3.673

7.  Protein z exerts pro-angiogenic effects and upregulates CXCR4.

Authors:  Antje Butschkau; Nana-Maria Wagner; Berit Genz; Brigitte Vollmar
Journal:  PLoS One       Date:  2014-12-04       Impact factor: 3.240

8.  Production and control of coagulation proteins for factor X activation in human endothelial cells and fibroblasts.

Authors:  Clay T Cohen; Nancy A Turner; Joel L Moake
Journal:  Sci Rep       Date:  2020-02-06       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.